Mpi Indium Dtpa In 111

   
Google
 
Web NewDrugInformation.com

Mpi Indium Dtpa In 111


Drug - Mpi Indium Dtpa In 111
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INTRATHECAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Indium In-111 Pentetate Disodium
Multiple ingredients are in alphabetical order.

Strength - 1mCi/ML
The potency of the active ingredient(s), Indium In-111 Pentetate Disodium. May repeat for multiple part products.

Applicant - GE HEALTHCARE
The firm name holding legal responsibility for Mpi Indium Dtpa In 111. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017707
The FDA assigned number to Mpi Indium Dtpa In 111. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Mpi Indium Dtpa In 111. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 18, 1982
The date Mpi Indium Dtpa In 111 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mpi Indium Dtpa In 111. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Mpi Indium Dtpa In 111 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ge Healthcare
The full name of the firm holding legal responsibility for the new application of Mpi Indium Dtpa In 111.

Mpi Indium Dtpa In 111